Loading...
Dear readers,
This week, NEJM Journal Watch covered COVID-19–related topics including bamlanivimab in the outpatient setting, trends in COVID-19 mortality among critically ill patients, cardiac histopathology, durability of immunity to SARS-CoV-2, tocilizumab, allergic reactions to COVID-19 vaccines, and criteria for receiving corticosteroid therapy.
This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).
As always, we continue to provide our regular coverage of other important infectious diseases research.